Log in
NICE

NICE NG109 2018: lower UTI antimicrobial prescribing guidelines

This guideline covers the antimicrobial management of lower urinary tract infection in women, men, pregnant women, and children, aiming to promote effective empirical and targeted antibiotic use while limiting resistance. It gives first- and second-choice antibiotic options stratified by patient group and risk factors, and emphasizes using back-up or delayed prescribing strategies and sending urine cultures selectively.

NICE2018 editionSummary
Official guidelineUrinary tract infection (lower): antimicrobial prescribing (NG109). NICE, 2018.
Read the official guideline · Checked for a newer edition on 2026-10-20
We do not reproduce the guideline text — this page is an independent summary.

Who it applies to

Applies to adults, pregnant women, and children/young people with suspected or confirmed lower UTI (cystitis) managed in primary and community care.

Key recommendations

  • For non-pregnant women with suspected UTI, consider a midstream urine culture only if risk factors for resistance or complication are present, atypical symptoms, or treatment failure; otherwise diagnose clinically.
  • First-line empirical antibiotics for uncomplicated lower UTI in non-pregnant women are nitrofurantoin or trimethoprim, chosen with regard to local resistance data, depending on renal function for nitrofurantoin.
  • A 3-day course is recommended for non-pregnant women with uncomplicated lower UTI.
  • Men with lower UTI symptoms should be treated with a 7-day course of antibiotics, reflecting the possibility of occult prostatic involvement.
  • Pregnant women with symptomatic lower UTI should have a urine culture sent before starting antibiotics, with nitrofurantoin generally first line (avoided near term) and amoxicillin or cefalexin as alternatives depending on sensitivities.
  • Trimethoprim should be avoided in the first trimester of pregnancy due to teratogenic risk, and nitrofurantoin should be avoided at term due to risk of neonatal haemolysis.
  • For children and young people aged 3 months and older with suspected UTI, a urine sample should be sent for culture before starting antibiotics, and a 3-day course of either trimethoprim or nitrofurantoin is recommended as first-choice empirical treatment; specialist advice is reserved for infants under 3 months.
  • Second-choice agents (e.g., pivmecillinam, fosfomycin, or an alternative first-line agent) should be considered if there is no improvement on first-choice therapy after 48 hours or if first-choice agents are unsuitable.
  • Safety-netting advice should be given to all patients, including when to seek further medical review if symptoms worsen or do not improve.

Practice points for students

  • Nitrofurantoin should generally be avoided if eGFR is below 45 mL/min/1.73m2, though it may still be used cautiously in some circumstances with lower eGFR for short courses.
  • Men are treated for 7 days, not 3 days, because of the risk of occult prostatic involvement.
  • Trimethoprim carries teratogenicity risk in early pregnancy due to folate antagonism, so alternatives are preferred in the first trimester.
  • In children aged 3 months and older, a 3-day course of trimethoprim or nitrofurantoin is first-line, while infants under 3 months need specialist advice.

Condition

Urinary tract infection

Other guidelines on this topic

Independent educational summary written by the WhiteCoat Pro editorial team with AI assistance and checked by a second AI model. It does not reproduce the guideline text, tables or figures, and it is not affiliated with or endorsed by NICE. It is not medical advice: always read the original guideline before applying it to patients.